儿童和年轻成年人使用药物治疗注意力缺陷多动性障碍面临心脏风险增加
Howaida Elmowafi1, Jenny M Kindblom2,3, Linda Halldner4,5
1Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden.
治疗注意力缺陷多动症 (ADHD) 的药物与年轻人的心脏事件有关,特别是未定义的心律失常. 先天性心脏病并没有增加这种风险.
科学领域:
- 心脏病学 心脏病学
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 对于儿童和年轻成年人群中注意力缺陷多动症 (ADHD) 药物的心脏安全性存在担忧.
- 了解潜在的关联对于临床决策和患者福祉至关重要.
研究的目的:
- 调查5-30岁个体使用多动症药物和心脏事件之间的关联.
- 为了确定与ADHD药物相关的特定类型的心脏事件.
主要方法:
- 一项瑞典全国性的病例控制研究利用了2006-2018年的注册数据.
- 112,605例心脏骤停,心律失常,昏或崩的病例与563,024例对照病例相匹配.
- 调整后的几率比 (aOR) 评估了相关性,控制了药物和先天性心脏病 (CHD) 等并发症.
主要成果:
- 使用ADHD药物与心脏事件的风险增加有关 (aOR 1.63).
- 不确定的心律失常显示出最强的关联 (aOR 2.66).
- 长期使用ADHD药物也与风险增加相关 (aOR1.20),而先天性心脏病没有显著影响.
结论:
- 治疗ADHD的药物与心脏事件的风险增加有关,特别是未定义的心律失常.
- 遗传性心脏病似乎没有改变这种风险.
更多相关视频
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
相关概念视频
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Factors Affecting Drug Response: Overview
